Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Safety and Pharmacokinetics Study of TRN501 in Healthy Japanese Adult Males
jRCT2031230689Phase 1Completed
- Sponsor
- SNLD
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Parkinson's disease (PD) comparing TRN501 with Placebo (2 arms). Primary endpoint: Safety evaluation of TRN501. Started Jun 2024; status: completed.
02
Drugs
TRN501
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2031230689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230689.